Karen J. Cassidy
Private Equity Investor chez Partisan Management Group, Inc.
Profil
Karen J.
Cassidy is the founder of AtriCure, Inc., Enable Medical Corp., Medivance, Inc. She is currently the Managing Director at Partisan Management Group, Inc. Her former positions include CEO at Impla-Med, Inc., Director & Vice President-Business Development at TriSalus Operating Life Sciences, Inc., Vice President at Corvita Corp., and Vice President at Symbiosis Corp.
Postes actifs de Karen J. Cassidy
| Sociétés | Poste | Début |
|---|---|---|
Partisan Management Group, Inc.
 Partisan Management Group, Inc. Investment ManagersFinance Partisan Management Group, Inc. (Partisan Management) is a venture capital firm founded in 1987. The firm is headquartered in Boulder, Colorado. | Private Equity Investor | - |
Anciens postes connus de Karen J. Cassidy
| Sociétés | Poste | Fin |
|---|---|---|
Enable Medical Corp.
 Enable Medical Corp. Medical SpecialtiesHealth Technology Enable Medical Corp. manufactures medical equipment for the treatment of bipolar patients. The company is based in West Chester, OH. D'Augustine. The company was founded by Norman R. Weldon, Michael D. Hooven, Rick J. Enable Medical was acquired by AtriCure, Inc. on August 10, 2005 for $7 million. | Fondateur | - |
| ATRICURE, INC. | Fondateur | - |
Symbiosis Corp.
 Symbiosis Corp. Pharmaceuticals: MajorHealth Technology Symbiosis Corp. was manufactures surgical instruments and medical use. The company was headquartered in Tallahassee, FL. | Corporate Officer/Principal | - |
Corvita Corp.
 Corvita Corp. Medical SpecialtiesHealth Technology Corvita Corporation is a development stage company engaged primarily in research and development of new medical devices and related biomaterials for treatment of late stage vascular disease. The company is sponsoring two FDA controlled, randomized prospective trials in the US for its peripheral grafts and AV access grafts, both of which are approved for sale in the European Common Market. In addition, Corvita is conducting clinical tests in Europe and plans to begin FDA controlled clinical studies in the US of the Corvita Endoluminal Graft, a new less invasive product for lower cost treatment of vascular trauma, vascular occlusive disease and aneurysmal disease. The majority of the company's activities in FY 96 will be focused on development and testing of Corvita Endoluminal Grafts. | Corporate Officer/Principal | - |
| Impla-Med, Inc. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ATRICURE, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Medivance, Inc.
 Medivance, Inc. Medical SpecialtiesHealth Technology Medivance, Inc. develops, manufactures and markets therapeutic temperature management products. The company was founded in 1998 and is headquartered in Louisville, CO. | Health Technology |
Partisan Management Group, Inc.
Partisan Management Group, Inc. Investment ManagersFinance Partisan Management Group, Inc. (Partisan Management) is a venture capital firm founded in 1987. The firm is headquartered in Boulder, Colorado. | Finance |
TriSalus Operating Life Sciences, Inc.
 TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | Health Technology |
| Impla-Med, Inc. | Health Technology |
Corvita Corp.
Corvita Corp. Medical SpecialtiesHealth Technology Corvita Corporation is a development stage company engaged primarily in research and development of new medical devices and related biomaterials for treatment of late stage vascular disease. The company is sponsoring two FDA controlled, randomized prospective trials in the US for its peripheral grafts and AV access grafts, both of which are approved for sale in the European Common Market. In addition, Corvita is conducting clinical tests in Europe and plans to begin FDA controlled clinical studies in the US of the Corvita Endoluminal Graft, a new less invasive product for lower cost treatment of vascular trauma, vascular occlusive disease and aneurysmal disease. The majority of the company's activities in FY 96 will be focused on development and testing of Corvita Endoluminal Grafts. | Health Technology |
Symbiosis Corp.
Symbiosis Corp. Pharmaceuticals: MajorHealth Technology Symbiosis Corp. was manufactures surgical instruments and medical use. The company was headquartered in Tallahassee, FL. | Health Technology |
Enable Medical Corp.
Enable Medical Corp. Medical SpecialtiesHealth Technology Enable Medical Corp. manufactures medical equipment for the treatment of bipolar patients. The company is based in West Chester, OH. D'Augustine. The company was founded by Norman R. Weldon, Michael D. Hooven, Rick J. Enable Medical was acquired by AtriCure, Inc. on August 10, 2005 for $7 million. | Health Technology |
